ShareHope Medicine Co., Ltd. Stock

Equities

8403

TW0008403007

Pharmaceuticals

End-of-day quote Taipei Exchange 06:00:00 2024-04-25 pm EDT 5-day change 1st Jan Change
31.4 TWD -0.48% Intraday chart for ShareHope Medicine Co., Ltd. +0.16% -4.56%
Sales 2022 4.14B 127M Sales 2023 3.87B 119M Capitalization 4.15B 127M
Net income 2022 294M 9.02M Net income 2023 125M 3.84M EV / Sales 2022 1.09 x
Net Debt 2022 460M 14.12M Net Debt 2023 787M 24.14M EV / Sales 2023 1.27 x
P/E ratio 2022
13.9 x
P/E ratio 2023
33.6 x
Employees -
Yield 2022
1.48%
Yield 2023
-
Free-Float 64.37%
More Fundamentals * Assessed data
Dynamic Chart
ShareHope Medicine Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
ShareHope Medicine Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
ShareHope Medicine Co., Ltd.(TPEX:8403) added to S&P Global BMI Index CI
ShareHope Medicine Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
ShareHope Medicine Co., Ltd. Announces Election of Yao Xiubi as Members of the Audit Committee CI
ShareHope Medicine Co., Ltd. Elects Board of Directors CI
ShareHope Medicine Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
ShareHope Medicine Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
ShareHope Medicine Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
ShareHope Medicine Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI
ShareHope Medicine Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
ShareHope Medicine Co., Ltd. announced that it expects to receive TWD 57.16293 million in funding CI
ShareHope Medicine Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021 CI
ShareHope Medicine Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021 CI
Sharehope Medicine Co., Ltd. Reports Earnings Results for the Second Quarter Ended June 30, 2021 CI
More news
1 day-0.48%
1 week+0.16%
Current month-0.16%
1 month+0.32%
3 months-4.56%
6 months-2.03%
Current year-4.56%
More quotes
1 week
31.15
Extreme 31.15
31.80
1 month
30.50
Extreme 30.5
32.55
Current year
30.50
Extreme 30.5
33.95
1 year
30.50
Extreme 30.5
44.10
3 years
23.04
Extreme 23.0385
44.10
5 years
19.84
Extreme 19.8387
45.36
10 years
19.66
Extreme 19.6648
45.36
More quotes
Managers TitleAgeSince
Chief Executive Officer 55 03-11-03
Director/Board Member - 05-05-31
Investor Relations Contact - -
Members of the board TitleAgeSince
Director/Board Member - 05-05-31
Director/Board Member - 03-09-09
Director/Board Member - 03-09-09
More insiders
Date Price Change Volume
24-04-26 31.4 -0.48% 138,581
24-04-25 31.55 +0.80% 182,457
24-04-24 31.3 +0.16% 132,956
24-04-23 31.25 0.00% 70,995
24-04-22 31.25 -0.32% 109,107

End-of-day quote Taipei Exchange, April 25, 2024

More quotes
ShareHope Medicine Co., Ltd. is principally engaged in the supply of pharmaceuticals, medical materials and technology materials. The Company is also engaged in the provision of medical health check and medical testing laboratories management consulting and entrusted operation services, the leasing of equipment and the provision of long-term care services. The Company operates its business through five segments: pharmaceutical distribution, health management, technology materials, hospitals and others. The Company distributes its products within domestic market and to overseas markets.
More about the company